Pivotal Point Tracking Thermo Fisher Scientific (TMO): US Laboratory Supplier Raises Annual Outlook After 10% Revenue Increase in Q2
Reading Time: 1 minute
Thermo Fisher Scientific is the world's leading provider in the service of science, offering instruments, consumables, and software for research, diagnostics, and pharmaceuticals. On July 23, the company impressed with strong numbers for Q2 2026 and raised its annual outlook. Revenue rose by 10% to $11.99 billion with an organic increase of 5%. The adjusted earnings per share climbed by 13% to $6.03. The driving force was the operating result of $2.73 billion. Management raised the annual outlook for revenue to $47.4 to $48.1 billion and for adjusted...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

